0000897069-24-000917.txt : 20240412 0000897069-24-000917.hdr.sgml : 20240412 20240412165041 ACCESSION NUMBER: 0000897069-24-000917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guy Wendy CENTRAL INDEX KEY: 0001799360 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39531 FILM NUMBER: 24842120 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 4 1 form4.xml X0508 4 2024-01-01 0001533743 Processa Pharmaceuticals, Inc. PCSA 0001799360 Guy Wendy C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076 true Chief Administrative Officer false Common Stock 2024-01-01 4 M 0 1675 A 11801 D Common Stock 2024-01-01 4 F 0 368 2.79 D 11433 D Common Stock 8335 I By CorLyst, LLC Restricted Stock Units 0 2024-01-01 4 M 0 1675 0 D Common Stock 1675 20132 D Distribution of vested restricted shares. Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. /s/ Wendy Guy by Michael B. Kirwan, as Attorney-in-Fact 2024-04-12